Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 2

Conditions

Neoplasms 24Breast Neoplasms 11Prostatic Neoplasms 10Colorectal Neoplasms 10Hematologic Neoplasms 7Ovarian Neoplasms 6Lung Neoplasms 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Multiple Myeloma 4Advanced Cancer 4Uterine Cervical Neoplasms 3Rectal Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3Gastrointestinal Neoplasms 3Sarcoma 2Peritoneal Neoplasms 2Pain 2Neoplasm Metastasis 2Mouth Neoplasms 2Melanoma 2Low Anterior Resection Syndrome 2Hematopoietic and Lymphoid System Neoplasm 2Fatigue 2Endometrial Neoplasms 2Depression 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Colonic Neoplasms 2Brain Neoplasms 2Bone Neoplasms 2

Interventions

Ipilimumab 114pembrolizumab 94Nivolumab 91aldesleukin 86Interleukin-2 57Cyclophosphamide 54Dacarbazine 52Vemurafenib 39trametinib 37Temozolomide 37incomplete Freund's adjuvant 35fludarabine phosphate 35sargramostim 32dabrafenib 32fludarabine 26Bevacizumab 26Paclitaxel 22MART-1 Antigen 21Granulocyte-Macrophage Colony-Stimulating Factor 21montanide ISA 51 20Interferon-alpha 20Cisplatin 20Carboplatin 19Sorafenib 18Introns 17Biopsy 17cobimetinib 16Radiosurgery 16atezolizumab 15Radiotherapy 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Melanoma × Interviews as Topic × Clear all
NCT00510302 2020-09-16

Melanoma Risk-Reduction Among Patients and Family Members

M.D. Anderson Cancer Center

Completed
170 enrolled
Dermatologic

Melanoma

NCT00394134 2019-09-13

Targeted Intervention for Melanoma Prevention

M.D. Anderson Cancer Center

Phase NA Completed
205 enrolled
Dermatologic

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡